Patent US3048991A successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0563296B1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Optimization of binding proteins

Assignee: Applied Molecular Evolution Inc
•
Filing: 1991-12-20
•
Granted: 1999-03-17
•
Expires: 2011-12-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to methods for manipulating nucleic acids so as to optimize the binding characteristics of an encoded binding protein by providing two or more nucleic acids encoding binding proteins having at least one set of splicing sites, the set of splicing sites flanking opposite ends of one or more encoded binding domains; mixing the nucleic acids to produce a parent population of mixed nucleic acids encoding binding proteins; and randomly incorporating the binding domains between the nucleic acids through the set of splicing sites to produce a different population of nucleic acids encoding binding proteins wherein at least one binding protein is characterized by substantially different binding characteristics than a member of the parent population.

Inventors

  • 👤 William D. Huse

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-04 16:26
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/46; C07K16/461; C07K16/464; C07K2317/00; C07K2317/20; C07K2317/24; C07K2319/00

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 216 words
A method for manipulating nucleic acids so as to optimize the binding characteristics of an encoded binding protein to a particular ligand, said binding protein selected from the group consisting of antibodies and T cell receptors said method comprising the steps of: (a) providing two or more nucleic acids encoding different binding proteins all having binding affinity for said particular ligand, said binding proteins selected from the group consisting of antibodies and T cell receptors, said nucleic acids having at least one set of splicing sites, said set of splicing sites flanking opposite ends of one or more encoded complementarity determining regions (CDRs); (b) mixing said two or more nucleic acids to produce a parent population of mixed nucleic acids encoding said binding proteins; (c) randomly incorporating said one or more encoded CDRs between said two or more nucleic acids through said set of splicing sites to produce a different population of nucleic acids than said parent population, wherein at least one binding protein encoded by said different population is characterized by optimized binding characteristics as compared with a member of the parent population; and (d) selecting from said different population at least one of the nucleic acids encoding a binding protein characterized by optimized binding characteristics as compared with a member of the parent population.
Claim 2
Dependent Claim 24 words
The method of claim 1, wherein step (a) further comprises synthesis of at least one nucleic acid encoding a binding protein by enzymatic polymerization.
Claim 3
Dependent Claim 14 words
The method of claim 2, wherein said enzymatic polymerization is a polymerase chain reaction.
Claim 4
Dependent Claim 22 words
The method of claim 1, wherein step (a) further comprises chemical synthesis of at least one nucleic acid encoding a binding protein.
Claim 5
Dependent Claim 81 words
The method of claim 1, wherein step (c) further comprises: (c1) introducing at least one set of cleavage sites within said parent population of mixed nucleic acids at said splicing sites; (c2) cleaving said cleavage sites with a cleaving reagent to produce termini at each splicing site which are non-compatible for ligation and releasing said one or more encoded CDRs from said nucleic acids encoding binding proteins; and (c3) ligating said released encoded CDRs to said nucleic acids encoding binding proteins.
Claim 6
Dependent Claim 40 words
The method of claim 2, wherein step (c) further comprises annealing single strand regions of said splicing sites between said two or more nucleic acids, said splicing sites having sufficient nucleotide sequence identity between complementary strands to allow specific hybridization.
Claim 7
Dependent Claim 14 words
The method of claim 6, wherein said two or more nucleic acids are single-stranded.
Claim 8
Dependent Claim 40 words
The method of claim 4, wherein step (c) further comprises annealing single stranded regions of said splicing sites between said two or more nucleic acids said splicing sites having sufficient nucleotide sequence identity between complementary strands to allow specific hybridization.
Claim 9
Dependent Claim 14 words
The method of claim 8, wherein said two or more nucleic acids are single-stranded.
Claim 10
Dependent Claim 11 words
The method of claim 1, wherein said binding proteins are antibodies.
Claim 11
Dependent Claim 13 words
The method of claim 1, wherein said binding proteins are T cell receptors.
Claim 12
Dependent Claim 16 words
The method of claim 5, wherein said set of cleavage sites are restriction enzyme recognition sites.
Claim 13
Dependent Claim 25 words
The method of claim 12 wherein said restriction enzyme recognition sites are selected from the group consisting of Bst XI, Fok I and Dra III.
Claim 14
Dependent Claim 13 words
The method of claim 5, wherein said cleaving reagent is a restriction enzyme.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag